Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

被引:51
|
作者
Sepehr, A
Tanière, P
Martel-Planche, G
Zia'ee, AA
Rastgar-Jazii, F
Yazdanbod, M
Etemad-Moghadam, G
Kamangar, F
Saidi, F
Hainaut, P
机构
[1] IARC, Grp Mol Carcinogenesis, F-69008 Lyon, France
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[3] NRCGEB, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Surg, Tehran, Iran
[5] Iran Mehr Hosp, Dept Pathol, Tehran, Iran
[6] Iran Mehr Hosp, Dept Surg, Tehran, Iran
[7] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
esophagus; neoplasms; Iran; p53; COX-2;
D O I
10.1038/sj.onc.1204912
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE), are observed in Iran,, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations, in SCCE,: TP53: mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5-8): in 98 SCCE from Iran by temporal temperature get electrophoresis and direct sequencing. We found 58, mutations, in 49 patients, (50%,), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was significantly different from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007)., Moreover, the prevalence of mutations at A:T base pairs, (transitions and transversions) was higher in men than in women (38.7%, vs 11.1%, P=0.033). COX-2 overexpression was, detected in 69% of the cases evaluated (24/35), without significant association with TP53, mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess, levels of nitric oxide, was observed in tumor cells, in six of 16 cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis, in Iran., These factors include a baseline of chronic inflammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk.
引用
收藏
页码:7368 / 7374
页数:7
相关论文
共 50 条
  • [21] Truncating TP53 mutations have prognostic significance in head and neck squamous cell carcinoma
    van der Plas, Marlon
    Brakenhoff, Ruud H.
    Kuik, Dirk J.
    Buijze, Marijke
    Bloemena, Elisabeth
    Snijders, Peter Jf
    Leemans, C. Rene
    Braakhuis, Boudewijn Jm
    CANCER RESEARCH, 2011, 71
  • [22] tp53 DNA contact mutations are associated with metastasis in head and neck squamous cell carcinoma
    Erber, R
    Homann, N
    Conradt, C
    Finckh, M
    Dietz, A
    Weidauer, H
    Bosch, FX
    BRITISH JOURNAL OF CANCER, 1998, 77 : 7 - 7
  • [23] Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
    Loeb, Keith R.
    Asgari, Maryam M.
    Hawes, Stephen E.
    Feng, Qinghua
    Stern, Joshua E.
    Jiang, Mingjun
    Argenyi, Zsolt B.
    de Villiers, Ethel-Michele
    Kiviat, Nancy B.
    PLOS ONE, 2012, 7 (04):
  • [24] Extremely High Tp53 Mutation Load in Esophageal Squamous Cell Carcinoma in Golestan Province, Iran
    Abedi-Ardekani, Behnoush
    Kamangar, Farin
    Sotoudeh, Masoud
    Villar, Stephanie
    Islami, Farhad
    Aghcheli, Karim
    Nasrollahzadeh, Dariush
    Taghavi, Noushin
    Dawsey, Sanford M.
    Abnet, Christian C.
    Hewitt, Stephen M.
    Fahimi, Saman
    Saidi, Farrokh
    Brennan, Paul
    Boffetta, Paolo
    Malekzadeh, Reza
    Hainaut, Pierre
    PLOS ONE, 2011, 6 (12):
  • [25] TP53 Wild-type Esophageal Squamous Cell Carcinoma Demonstrates Distinct Oncogenic Pathways
    Goksel, Behiye
    Zhao, Lei
    LABORATORY INVESTIGATION, 2023, 103 (03) : S554 - S555
  • [26] TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
    Zhou, Ge
    Liu, Zhiyi
    Myers, Jeffrey N.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (12) : 2682 - 2692
  • [27] HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common
    Kashofer, Karl
    Winter, Elke
    Halbwedl, Iris
    Thueringer, Andrea
    Kreiner, Marisa
    Sauer, Stefan
    Regauer, Sigrid
    MODERN PATHOLOGY, 2017, 30 (07) : 1013 - 1020
  • [28] TP53 codon 72 polymorphism in oral squamous cell carcinoma
    Drummond, SN
    De Marco, L
    Pordeus, ID
    Barbosa, AA
    Gomez, RS
    ANTICANCER RESEARCH, 2002, 22 (6A) : 3379 - 3381
  • [29] TP53 mutations in malignant and premalignant Barrett's esophagus
    Dolan, K
    Walker, SJ
    Gosney, J
    Field, JK
    Sutton, R
    DISEASES OF THE ESOPHAGUS, 2003, 16 (02) : 83 - 89
  • [30] TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in South Thailand
    Tanière, P
    Martel-Planche, G
    Puttawibul, P
    Casson, A
    Montesano, R
    Chanvitan, A
    Hainaut, P
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (02) : 223 - 227